FGF23 and hypophosphatemia: PHEX is expressed in osteocytes and odontoblasts, and loss-of-function PHEX mutation results in excess circulating fibroblast growth factor 23 (FGF23), leading to hypophosphatemia (Kinoshita and Fukumoto, 2018).